Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: ICON plc (ICLR) drop 50% in Value is this justified!!!!!!!

No earlier versions found for this Subject.

Return to ICON plc (ICLR) drop 50% in Value is this justified!!!!!!!

ICON plc is a contract research organization (CRO) which provides clinical research and development services on a global basis to the pharmaceutical and biotechnology industries. For the six months ended 11/98, revenues rose 46% to $43.9 million. Net income rose from $1.6 million to $3.8 million. Revenues reflect increases in revenues from existing clients and an expanded customer base. Net income reflects improved staff utilization. They just reported earnings today.

Icon sees fiscal 1999 EPS up but below
estimates

NEW YORK, March 30 (Reuters) - Irish clinical research
company Icon Plc (Nasdaq:ICLR - news) said on Tuesday it
expects earnings per share for fiscal 1999 to rise more than 30
percent, rather than the more than 40 percent expected by
analysts, due to an undisclosed client downsizing a large project.